More Research on Pediatric Cancer Drugs
This act aims to accelerate research into new cancer drugs, especially molecularly targeted ones, for children. This could give children with cancer faster access to innovative therapies, increasing their chances of recovery and improving their quality of life. Pharmaceutical companies will be required to conduct studies on the use of adult cancer drugs in children.
Key points
Increased focus on research into pediatric cancer drugs, including molecularly targeted therapies.
Requirement for clinical and preclinical studies of cancer drugs in children to ensure appropriate dosing and safety.
Possibility of testing drugs in combination with other substances, potentially increasing treatment effectiveness.
Accelerated access for children to modern cancer therapies.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.